The Drug Eluting Stents Center

Filter Your Results




Cook’s Zilver PTX Compares Favorably to PTA for SFA Treatment in Diabetic Patients

June 18, 2011 -- The Society for Vascular Surgery (SVS) announced that results of a prospective, randomized trial indicate that the Zilver PTX paclitaxel-eluting stent (Cook M…

Cordis to Exit Drug-Eluting Stent Market

June 15, 2011 -- Cordis Corporation (Bridgewater, NJ) announced it will no longer pursue the development of the Nevo sirolimus-eluting coronary stent and will also stop manufa…

CE Mark Approval for Abbott Vascular's Xience Prime DES Expanded to Treatment of CLI

January 20, 2011 -- Abbott Vascular (Santa Clara, CA) announced that it has received CE Mark approval to market its Xience Prime everolimus-eluting coronary stent system for t…

Cook Medical's 2-Year Zilver PTX Trial Results Presented at ISET

January 17, 2011 -- Cook Medical (Bloomington, IN) announced that principal investigator Michael Dake, MD, presented 2-year results of the Zilver PTX trial at the Internationa…

Zilver PTX Trial Shows Benefits of DES in Treating SFA Disease

September 24, 2010 -- Principal investigator Michael D. Dake, MD, presented 1-year results from an evaluation of the Zilver PTX paclitaxel-eluting stent (Cook Medical, Bloomin…

Drug-Eluting Balloons in Below-the-Knee Applications

Jos C. Van Den Berg, MD, PhD

September 2010—A new technique for treating below-the-knee occlusive disease.

Cook Files PMA for FDA Approval of Zilver PTX DES

June 11, 2010 -- Cook Medical (Bloomington, IN) announced that it has submitted its premarket approval (PMA) application to the US Food and Drug Administration (FDA) for the c…

Interim 2-Year SFA Data Presented for Cook’s Zilver PTX Stent

May 7, 2010 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of interim results showing that patients with peripheral artery d…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.